United States:
ML Strategies Weekly Health Care Preview – July 9, 2018
To print this article, all you need is to be registered or login on Mondaq.com.
This week, Congress returns from recess to another four-week
work period. The dynamics of the next four weeks might be in flux
now that President Trump has nominated Brett Kavanaugh to the U.S.
Supreme Court. Other issues to monitor include the suspension of
risk adjustment payments and the fall out from the Kentucky
Medicaid waiver ruling. We cover all this and more in this
week’s preview, which you can find here.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
FDA Ramps Up Actions On PFAS
Holland & Knight
The U.S. Food and Drug Administration (FDA) has increased regulatory activity with regard to per- and polyfluoroalkyl substances (PFAS).
Planning For The BIOSECURE Act
Foley Hoag LLP
Bipartisan legislation moving through the U.S. House and Senate, known as the BIOSECURE Act, could limit the ability of U.S. life sciences companies...